CEPROTIN

This brand name is authorized in Austria, Croatia, Cyprus, Estonia, Finland, France, Ireland, Lithuania, Netherlands, Poland, Romania, South Africa, Spain, Turkey, UK.

Active ingredients

The drug CEPROTIN contains one active pharmaceutical ingredient (API):

1	Human protein C UNII 6D53G0FD0Z - PLASMA PROTEIN FRACTION (HUMAN)
	Protein C is a serine protease with potent anticoagulant effects, especially in the presence of its cofactor protein S. Protein C exerts its effect by the inactivation of the activated forms of factors V and VIII which leads to a decrease in thrombin formation. Protein C has also been shown to have profibrinolytic effects.
	Read more about Protein C

Medication package inserts

Below package inserts are available for further reading:

Document	Type	Information Source
CEPROTIN Powder and solvent for solution for injection	MPI, EU: SmPC	European Medicines Agency (EU)

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
B01AD12	Protein C	B Blood and blood forming organs → B01 Antithrombotic agents → B01A Antithrombotic agents → B01AD Enzymes
Discover more medicines within B01AD12

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
EE	Ravimiamet	1203321, 1203332
ES	Centro de información online de medicamentos de la AEMPS	01190001
FI	Lääkealan turvallisuus- ja kehittämiskeskus	007223, 007268
FR	Base de données publique des médicaments	63191266
GB	Medicines & Healthcare Products Regulatory Agency	95045, 95051
LT	Valstybinė vaistų kontrolės tarnyba	1028069, 1028070
NL	Z-Index G-Standaard	14715783
NL	Z-Index G-Standaard, PRK	61115
PL	Rejestru Produktów Leczniczych	100127157, 100127163
RO	Agenția Națională a Medicamentului și a Dispozitivelor Medicale	W66936001, W66937001
TR	İlaç ve Tıbbi Cihaz Kurumu	8681429550257
ZA	Health Products Regulatory Authority	A39/30.4/0417, A39/30.4/0418